Stayble Therapeutics AB (publ) (FRA:4K4)

Market Cap	1.22M -44.9%
Revenue (ttm)	-1.55K
Net Income	-979.33K
EPS	n/a
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	55,948
Open	0.0230
Previous Close	0.0226
Day's Range	0.0230 - 0.0230
52-Week Range	0.0024 - 0.0489
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 20, 2026

About Stayble Therapeutics AB

Stayble Therapeutics AB (publ) a clinical pharmaceutical company, developing an injection-based treatments for disc herniation. It develops STA363, an injection into the disc that targets chronic low back and leg pain. The company was incorporated in 2015 and is based in Gothenburg, Sweden.

• Industry: Pharmaceutical Preparations
• Founded: 2015
• Employees: 2
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 4K4

Financial Performance

Financial numbers in SEK

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 27, 2026

Data Sources Report a data error